STOCK TITAN

Vor Bio To Participate in Upcoming September Conferences

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Vor Bio (Nasdaq: VOR) announced management participation in several September 2026 investor events, including the Wells Fargo Healthcare Conference on September 8 (8:00AM ET), Citi’s Biopharma Back to School Conference on September 9 (11:20AM ET), Morgan Stanley’s Global Healthcare Conference on September 14, Baird’s Global Healthcare Conference on September 15 (9:05AM ET), and Stifel’s Virtual Immunology and Inflammation Forum on September 23 (11:30AM ET). A live webcast and 30-day replay of presentations will be available on Vor Bio’s investor relations website.

Loading...
Loading translation...
Argus Sep 1 session 50 alerts
+0.71% close to close 2.0x rel. volume Open Argus
Details

News Market Reaction – VOR

+5.3% Peak in 5 hr 26 min
$1.47B Mkt Cap at Peak Alert

On Sep 1, the day this news came out, VOR closed 0.71% above the previous close. Argus tracked a peak move of +5.3% during that session. Our momentum scanner recorded 50 alerts in the available session data. Relative volume reached 2.0x the daily average during tracking.

Data tracked by StockTitan Argus for the Sep 1 session.

Key Figures

Wells Fargo conference date: September 8th Citi conference date: September 9th Morgan Stanley conference date: September 14th +3 more
Wells Fargo conference date
September 8th
21st Annual Healthcare Conference Forum
Citi conference date
September 9th
2026 Biopharma Back to School Conference Forum
Morgan Stanley conference date
September 14th
24th Annual Global Healthcare Conference Forum
Baird conference date
September 15th
2026 Global Healthcare Conference Forum
Stifel forum date
September 23rd
2026 Virtual Immunology and Inflammation Forum
Webcast replay availability
approximately 30 days
Following the presentation

Historical Context

5 past events · Latest: Aug 11
5 events
  1. Aug 11

    2Q26 earnings report

    24h Move
    +0.9%

    Phase 3 enrollment continued, with projected funding into early 2029.

  2. Aug 03

    Inducement grant

    24h Move
    +3.9%

    Equity awards were granted to five newly hired employees.

  3. Jul 07

    Board appointment

    24h Move
    +1.0%

    David Zaccardelli joined the board as global Phase 3 development advanced.

  4. Jul 02

    Inducement grant

    24h Move
    -2.4%

    Equity awards were granted to seven newly hired employees.

  5. Jun 08

    NMPA approval

    24h Move
    +1.0%

    China's NMPA approved telitacicept for adult Sjögren’s disease.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in the following investor conferences:

  • Wells Fargo 21st Annual Healthcare Conference

                        Forum: Fireside Chat and 1x1 Meetings
                        Date: Tuesday, September 8th
                        Presentation Time: 8:00AM ET

  • Citi’s 2026 Biopharma Back to School Conference

                        Forum: Fireside Chat and 1x1 Meetings
                        Date: Wednesday, September 9th
                        Presentation Time: 11:20AM ET

  • Morgan Stanley 24th Annual Global Healthcare Conference

                        Forum: 1x1 Meetings
                        Date: Monday, September 14th

  • Baird’s 2026 Global Healthcare Conference

                        Forum: Presentation and 1x1 Meetings
                        Date: Tuesday, September 15th
                        Presentation Time: 9:05AM ET

  • Stifel’s 2026 Virtual Immunology and Inflammation Forum

                        Forum: Presentation and 1x1 Meetings
                        Date: Wednesday, September 23rd
                        Presentation Time: 11:30AM ET

A live webcast of the presentation may be accessed on the Investors section of the Vor website at ir.vorbio.com. A replay of the webcast will be available on the Vor website for approximately 30 days following the presentation.

About Vor Bio
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com. Vor Bio routinely posts information that may be important to investors in the “Investors” section of its website. The Company encourages investors to consult that section of its website regularly.



Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What September 2026 investor conferences will Vor Bio (Nasdaq: VOR) attend?

Vor Bio will participate in multiple September 2026 healthcare investor conferences, including events hosted by Wells Fargo, Citi, Morgan Stanley, Baird, and Stifel. According to Vor Bio, these appearances include fireside chats, presentations, and 1x1 investor meetings across several dates.

When is Vor Bio presenting at the Wells Fargo 21st Annual Healthcare Conference in 2026?

Vor Bio’s management is scheduled for a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, 2026, at 8:00AM ET. According to Vor Bio, the format includes both a fireside chat and 1x1 investor meetings.

What is the presentation time for Vor Bio at Citi’s 2026 Biopharma Back to School Conference (VOR)?

Vor Bio will present at Citi’s 2026 Biopharma Back to School Conference on Wednesday, September 9, 2026, at 11:20AM ET. According to Vor Bio, this event will feature a fireside chat and opportunities for 1x1 investor meetings.

How can investors access the Vor Bio (VOR) webcasts for its September 2026 conferences?

Investors can access live webcasts of Vor Bio’s conference presentations via the Investors section of the company’s website at ir.vorbio.com. According to Vor Bio, webcast replays will remain available on the site for approximately 30 days after each presentation.

Will Vor Bio have 1x1 investor meetings at its September 2026 conferences?

Vor Bio plans to hold 1x1 investor meetings at several September 2026 events, including the Wells Fargo, Citi, Morgan Stanley, Baird, and Stifel conferences. According to Vor Bio, some forums also include formal presentations or fireside chats.

On what dates will Vor Bio attend the Morgan Stanley, Baird, and Stifel 2026 healthcare forums?

Vor Bio will attend Morgan Stanley’s Global Healthcare Conference on Monday, September 14, Baird’s Global Healthcare Conference on Tuesday, September 15 (9:05AM ET), and Stifel’s Virtual Immunology and Inflammation Forum on Wednesday, September 23 (11:30AM ET). According to Vor Bio, formats include presentations and 1x1 meetings.

Keep reading